A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects

Clinical trial NCT06953063 · COMPLETED

Trial details

NCT number: NCT06953063
Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2025-05-15
Primary completion: 2025-12-15
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.